A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic ...

There are 15 Connecticut-headquartered companies that made the 2025 Fortune 500 list of largest U.S. corporations. Here's the ...

Jaime Almandoz, MD, is triple board-certified in internal medicine, endocrinology, and obesity medicine, and has completed ...

After experiencing high growth in the U.S. telehealth scene, Hims is taking its personalized obesity treatments ...